Xeno Transplants Corp. operates as a bio-technology research and development company. The company is headquartered in Vancouver, British Columbia and currently employs 0 full-time employees. The company went IPO on 2006-08-01. Xenotransplantation is defined as the transplantation of organs, cells and tissues from one species to another. The firm has one reportable segment, which is the development of products to address the shortage of human donor cells and organs for transplantation into patients. All the Company’s activities are located in the United States. The firm intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.
Follow-Up Questions
¿Quién es el CEO de Xeno Aeronautics Corp?
Elliot Lebowitz es el President de Xeno Aeronautics Corp, se unió a la empresa desde 2007.
¿Qué tal es el rendimiento del precio de la acción XENO?
El precio actual de XENO es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Xeno Aeronautics Corp?
Xeno Aeronautics Corp pertenece a la industria Biotechnology y el sector es Health Care
¿Cuál es la capitalización bursátil de Xeno Aeronautics Corp?
La capitalización bursátil actual de Xeno Aeronautics Corp es $0
